Emerson Electric Company (EMR)
Official siteINDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE
Market Cap: $88.13B
Last updated: Nov 17, 2026 at 4:42 PM ET
Emerson Electric Company (EMR) Statistics
Emerson Electric Company (EMR) has a market cap of $88.13B and an enterprise value of $98.50B. Its trailing P/E is 24.2x.
Total Valuation
Enterprise value is 11.77% above the market cap, as debt exceeds cash.
| Market Cap | $88.13B |
|---|---|
| Enterprise Value | $98.50B |
| Latest price (Nov 17, 2026) | $159.29 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 13, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Last Ex-Dividend Date | Nov 13, 2026 |
| Next Payment Date | Dec 10, 2026 |
| Fiscal Year End | September |
Valuation Ratios
Sales and book value multiples are 4.7x and 4.3x. Its year-end P/E ranged from 18.3x to 26.2x from 2016 to 2025.
| P/E Ratio | 24.2x |
|---|---|
| Forward P/E | 21.6x |
| P/S Ratio | 4.7x |
| Forward P/S | 4.4x |
| P/B Ratio | 4.3x |
| P/FCF Ratio | 25.2x |
| P/OCF Ratio | 22.2x |
| PEG Ratio | 2.2 |
Enterprise Valuation
Counting debt and cash, the company is valued at 18.8x EBITDA and 28.1x free cash flow.
| EV / Earnings | 36.6x |
|---|---|
| EV / Sales | 5.2x |
| EV / EBITDA | 18.8x |
| EV / EBIT | 25.8x |
| EV / FCF | 28.1x |
Price Statistics
The stock is up 25.32% over 52 weeks and trades 0.03% below its 50-day average.
| Beta (1Y) | 1.52 |
|---|---|
| 52-Week Change | +25.32% |
| 1-Month Change | -0.42% |
| 3-Month Change | +1.43% |
| 6-Month Change | +22.34% |
| 5-Year Change | +70.02% |
| 10-Year Change | +225.45% |
| Total Return (1Y) | +27.10% |
| Total Return (3Y CAGR) | +22.56% |
| Total Return (5Y CAGR) | +12.75% |
| Return vs SPY (1Y) | +14.58% |
| Max Drawdown (1Y) | -23.72% |
| Max Drawdown (3Y) | -29.61% |
| Sharpe Ratio (1Y) | 0.73 |
| Correlation with SPY (1Y) | 0.65 |
| 50-Day Average | $159.33 |
| 200-Day Average | $147.31 |
| 52-Week Range | $121.30 to $171.39 |
| RSI (14 Days) | 43.8 |
| Average Volume (20 Days) | 3.04M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.94x current liabilities, and total debt is 0.59x shareholder equity.
| Current Ratio | 0.94x |
|---|---|
| Quick Ratio | 0.70x |
| Debt / Equity | 0.59x |
| Debt / EBITDA | 2.30x |
| Debt / FCF | 3.44x |
| Interest Coverage | -25.84x |
Returns and Efficiency
Return on invested capital is 8.96% over the last 12 months, against a 5-year average of 7.43%.
| Return on Equity (ROE) | 12.98% |
|---|---|
| Return on Assets (ROA) | 6.44% |
| Return on Invested Capital (ROIC) | 8.96% |
| Return on Capital Employed (ROCE) | 12.06% |
| ROE (5Y Average) | 25.60% |
| ROA (5Y Average) | 11.22% |
| ROIC (5Y Average) | 7.43% |
| Asset Turnover | 0.45x |
| Inventory Turnover | 3.58x |
| Receivables Turnover | 5.96x |
| Cash Conversion Cycle | 95 days |
Taxes
Income tax took 22.81% of pretax income over the last 12 months.
| Income Tax (TTM) | $796.00M |
|---|---|
| Effective Tax Rate | 22.81% |
Scores
EMR has an Altman Z-Score of 4.68, in the safe zone above 2.99, and a Piotroski F-Score of 9 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.68 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 9 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $18.98B over the last 12 months is up 5.36% from the 12 months before.
| Revenue | $18.98B |
|---|---|
| Revenue Growth (YoY) | +5.36% |
| Gross Profit | $10.13B |
| Operating Income | $3.82B |
| Pretax Income | $3.49B |
| Net Income | $2.69B |
| EBITDA | $5.30B |
| EBIT | $3.82B |
| Reported EPS (TTM) | $6.57 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 49.61% of the $41.81B in total assets.
| Cash and Equivalents | $1.81B |
|---|---|
| Total Debt | $12.18B |
| Net Debt | $10.37B |
| Net Debt Per Share | $18.53 |
| Working Capital | -$601.00M |
| Shareholder Equity | $20.74B |
| Book Value Per Share | $37.06 |
| Tangible Book Value | -$5.81B |
| Total Assets | $41.81B |
| Total Liabilities | $21.06B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $443.00M of capital spending, operating cash flow left $3.54B of free cash flow.
| Operating Cash Flow | $3.98B |
|---|---|
| Capital Expenditures | $443.00M |
| Free Cash Flow | $3.54B |
| FCF Per Share | $6.34 |
| Depreciation and Amortization | $1.48B |
| Dividends Paid | $1.24B |
| Share Repurchases | $1.00B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 20.14%, against a 5-year average of 16.92%.
| Gross Margin | 53.36% |
|---|---|
| Operating Margin | 20.14% |
| Pretax Margin | 18.38% |
| Net Margin | 14.19% |
| EBITDA Margin | 27.93% |
| EBIT Margin | 20.14% |
| FCF Margin | 18.62% |
| Gross Margin (5Y Average) | 50.33% |
| Operating Margin (5Y Average) | 16.92% |
| Net Margin (5Y Average) | 29.64% |
Growth
Revenue grew 7.77% a year over 3 years, and EPS 13.87% a year.
| Revenue Growth (3Y CAGR) | +7.77% |
|---|---|
| Revenue Growth (5Y CAGR) | +7.98% |
| EPS Growth (3Y CAGR) | +13.87% |
| EPS Growth (5Y CAGR) | +9.89% |
| FCF Growth (3Y CAGR) | +134.54% |
| FCF Growth (5Y CAGR) | +2.20% |
| Operating Income Growth (3Y CAGR) | +11.81% |
| Book Value Per Share Growth (2Y CAGR) | -0.19% |
Dividends and Yields
EMR pays out 31.79% of earnings as dividends.
| Dividend Per Share (Annual) | $2.38 |
|---|---|
| Dividend Yield | 1.49% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +1.16% |
| Dividend Growth (5Y CAGR) | +1.29% |
| Payout Ratio | 31.79% |
| FCF Payout Ratio | 35.19% |
| Earnings Yield | 4.13% |
| FCF Yield | 3.97% |
| Buyback Yield | 1.12% |
| Shareholder Yield | 2.52% |
Stock Splits
The last split was a 2-for-1 forward split on Dec 12, 2006.
| Last Split Date | Dec 12, 2006 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, EMR has the 8th highest P/E and the 5th highest P/S.
P/E RatioPeer median 25.2x
P/S RatioPeer median 4.0x
ROICPeer median 11.37%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.10%
Dividend YieldPeer median 1.10%
| P/E Ratio | 24.2x vs 25.2x median |
|---|---|
| P/S Ratio | 4.7x vs 4.0x median |
| ROIC | 8.96% vs 11.37% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.36% vs +8.10% median |
| Dividend Yield | 1.49% vs 1.10% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.31% and EPS growth at 10.57% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.31% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +10.57% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About EMR
What is EMR's market cap?
Emerson Electric Company has a market cap of $88.13B. Its enterprise value, which adds debt and subtracts cash, is $98.50B.
What is EMR's P/E ratio?
Emerson Electric Company has a trailing P/E ratio of 24.2x and a forward P/E of 21.6x.
How many shares of EMR are outstanding?
Emerson Electric Company has 559.60M shares outstanding. The count is down 0.59% from a year earlier.
Does EMR pay a dividend?
Yes. Emerson Electric Company pays $2.38 a share a year, a dividend yield of 1.49%.
How much debt does EMR have?
Emerson Electric Company has $12.18B of total debt and $1.81B of cash and equivalents, a net debt position of $10.37B.
EMR pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts